Literature DB >> 9801303

Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts.

M Scherr1, J J Rossi.   

Abstract

A major concern for antisense experiments is the prediction of effective oligonucleotide binding sites. We have developed a system to carry out oligodeoxyribonucleotide-RNA and ribozyme-RNA binding experiments in cell extracts to create a protein environment known to directly influence the structure of the mRNA. In these experiments the native, endogenous mRNA is probed using oligodeoxyribonucleotides (ODNs) to identify RNase H-accessible sites. The resulting RNase H-mediated cleavages in the cell extracts were quantified using RT-PCR with fluorescein and rhodaminetagged primers to generate fluorescent products that are analyzed and quantified on an automated DNA sequencer. As a model substrate for testing this system, we have targeted the murine DNA methyltransferase (MTase) mRNA. An ODN binding site in native MTase mRNA was identified that was cleaved by endogenous RNase H with an efficiency of 85% in the extracts. The ODN that was most effective in the cell extracts was also found to provide the best activity in vivo , resulting in a 75-85% reduction of the MTase mRNA. These data support the use of cell extracts and native transcripts to identify antisense and perhaps ribozyme target sites.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9801303      PMCID: PMC147980          DOI: 10.1093/nar/26.22.5079

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  16 in total

1.  Identifying ribozyme-accessible sites using NUH triplet-targeting gapmers.

Authors:  A A Mir; T J Lockett; P Hendry
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Secondary structure prediction and in vitro accessibility of mRNA as tools in the selection of target sites for ribozymes.

Authors:  M Amarzguioui; G Brede; E Babaie; M Grotli; B Sproat; H Prydz
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

3.  HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.

Authors:  B Bramlage; E Luzi; F Eckstein
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

Review 4.  Bottlenecks in development of retinal therapeutic post-transcriptional gene silencing agents.

Authors:  Jack M Sullivan; Edwin H Yau; R Thomas Taggart; Mark C Butler; Tiffany A Kolniak
Journal:  Vision Res       Date:  2007-10-31       Impact factor: 1.886

5.  RNA accessibility prediction: a theoretical approach is consistent with experimental studies in cell extracts.

Authors:  M Scherr; J J Rossi; G Sczakiel; V Patzel
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

6.  A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.

Authors:  Edwin H Yau; Mark C Butler; Jack M Sullivan
Journal:  Exp Eye Res       Date:  2016-05-25       Impact factor: 3.467

7.  Mapping of accessible sites for oligonucleotide hybridization on hepatitis delta virus ribozymes.

Authors:  J Wrzesinski; M Legiewicz; J Ciesiołka
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

8.  Secondary structure and hybridization accessibility of hepatitis C virus 3'-terminal sequences.

Authors:  Robert M Smith; Cherie M Walton; Catherine H Wu; George Y Wu
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Improvement of RNA secondary structure prediction using RNase H cleavage and randomized oligonucleotides.

Authors:  Andrew D Kauffmann; Ryan J Campagna; Chantal B Bartels; Jessica L Childs-Disney
Journal:  Nucleic Acids Res       Date:  2009-07-13       Impact factor: 16.971

10.  mRNA fusion constructs serve in a general cell-based assay to profile oligonucleotide activity.

Authors:  Dieter Hüsken; Fred Asselbergs; Bernd Kinzel; Francois Natt; Jan Weiler; Pierre Martin; Robert Häner; Jonathan Hall
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.